Literature DB >> 26438105

A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.

Zehra Agha1, Zafar Iqbal2, Tjitske Kleefstra2, Christiane Zweier3, Rolph Pfundt2, Raheel Qamar4, Hans VAN Bokhoven2, Marjolein H Willemsen2.   

Abstract

This report is regarding a Dutch female with microcephaly, mild intellectual disability (ID), gonadal dysgenesis and dysmorphic facial features with synophrys. Upon genotyping, an ~455 kb de novo deletion encompassing the first exon of NRXN1 was found. Bidirectional sequencing of the coding exons of the NRXN1 alpha isoform was subsequently performed to investigate the possibility of a pathogenic mutation on the other allele, but we could not find any other mutation. Previously, many heterozygous mutations as well as microdeletions in NRXN1 were shown to be associated with ID, autism, schizophrenia, and other psychiatric and psychotic disorders. Our results are in agreement with other reports that show that NRXN1 deletions can lead to ID, microcephaly and mild dysmorphic features. However, this is the first report of gonadal dysgenesis being associated with such deletions. It is not clear whether there is a causal relationship between the NRXN1 deletion and gonadal dysgenesis, but it is of interest that the FSHR gene, which encodes the follicle-stimulating hormone receptor causative correlation that is mutated in ovarian dysgenesis, is located proximal to the NRXN1 gene. Given that most of the females carrying NRXN1 deletions have been diagnosed at a prepubertal age, gynecologic screening of female carriers of a NRXN1 deletion is warranted.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438105      PMCID: PMC6863645          DOI: 10.1017/S001667231500021X

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  26 in total

Review 1.  Genetic and epigenetic networks in intellectual disabilities.

Authors:  Hans van Bokhoven
Journal:  Annu Rev Genet       Date:  2011-09-09       Impact factor: 16.830

2.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay.

Authors:  Rachel D Burnside; Romela Pasion; Fady M Mikhail; Andrew J Carroll; Nathaniel H Robin; Erin L Youngs; Inder K Gadi; Elizabeth Keitges; Vikram L Jaswaney; Peter R Papenhausen; Venkateswara R Potluri; Hiba Risheg; Brooke Rush; Janice L Smith; Stuart Schwartz; James H Tepperberg; Merlin G Butler
Journal:  Hum Genet       Date:  2011-02-27       Impact factor: 4.132

3.  Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.

Authors:  Linh Duong; Laura L Klitten; Rikke S Møller; Andrés Ingason; Klaus D Jakobsen; Celina Skjødt; Michael Didriksen; Helle Hjalgrim; Thomas Werge; Niels Tommerup
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-02-15       Impact factor: 3.568

4.  Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action.

Authors:  M Geppert; M Khvotchev; V Krasnoperov; Y Goda; M Missler; R E Hammer; K Ichtchenko; A G Petrenko; T C Südhof
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Homozygosity mapping in outbred families with mental retardation.

Authors:  Janneke H M Schuurs-Hoeijmakers; Jayne Y Hehir-Kwa; Rolph Pfundt; Bregje W M van Bon; Nicole de Leeuw; Tjitske Kleefstra; Michèl A Willemsen; Ad Geurts van Kessel; Han G Brunner; Joris A Veltman; Hans van Bokhoven; Arjan P M de Brouwer; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

6.  Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.

Authors:  George Kirov; Dilihan Gumus; Wei Chen; Nadine Norton; Lyudmila Georgieva; Murat Sari; Michael C O'Donovan; Fikret Erdogan; Michael J Owen; Hans-Hilger Ropers; Reinhard Ullmann
Journal:  Hum Mol Genet       Date:  2007-11-06       Impact factor: 6.150

7.  Investigation of NRXN1 deletions: clinical and molecular characterization.

Authors:  Mindy Preston Dabell; Jill A Rosenfeld; Patricia Bader; Luis F Escobar; Dima El-Khechen; Stephanie E Vallee; Mary Beth Palko Dinulos; Cynthia Curry; Jamie Fisher; Raymond Tervo; Mark C Hannibal; Kiana Siefkas; Philip R Wyatt; Lauren Hughes; Rosemarie Smith; Sara Ellingwood; Yves Lacassie; Tracy Stroud; Sandra A Farrell; Pedro A Sanchez-Lara; Linda M Randolph; Dmitriy Niyazov; Cathy A Stevens; Cheri Schoonveld; David Skidmore; Sara MacKay; Judith H Miles; Manikum Moodley; Adam Huillet; Nicholas J Neill; Jay W Ellison; Blake C Ballif; Lisa G Shaffer
Journal:  Am J Med Genet A       Date:  2013-03-12       Impact factor: 2.802

8.  Neurexin-1 is required for synapse formation and larvae associative learning in Drosophila.

Authors:  Xiankun Zeng; Mingkuan Sun; Li Liu; Fading Chen; Liuchan Wei; Wei Xie
Journal:  FEBS Lett       Date:  2007-05-04       Impact factor: 4.124

9.  Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.

Authors:  Mark R Etherton; Cory A Blaiss; Craig M Powell; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

10.  Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.

Authors:  Michael S L Ching; Yiping Shen; Wen-Hann Tan; Shafali S Jeste; Eric M Morrow; Xiaoli Chen; Nahit M Mukaddes; Seung-Yun Yoo; Ellen Hanson; Rachel Hundley; Christina Austin; Ronald E Becker; Gerard T Berry; Katherine Driscoll; Elizabeth C Engle; Sandra Friedman; James F Gusella; Fuki M Hisama; Mira B Irons; Tina Lafiosca; Elaine LeClair; David T Miller; Michael Neessen; Jonathan D Picker; Leonard Rappaport; Cynthia M Rooney; Dean P Sarco; Joan M Stoler; Christopher A Walsh; Robert R Wolff; Ting Zhang; Ramzi H Nasir; Bai-Lin Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.